Massive bleeding from a gastric artery pseudoaneurysm in hepatocellular carcinoma treated with atezolizumab plus bevacizumab: A case report

BACKGROUND: The combination of atezolizumab (ATZ) and bevacizumab (BVZ) was approved as first-line systemic therapy for advanced hepatocellular carcinoma (HCC) owing to its superior rates of response and patient survival. However, ATZ + BVZ is associated with increased risk of upper gastrointestinal...

Descripción completa

Detalles Bibliográficos
Autores principales: Pang, Fu-Wen, Chen, Bin, Peng, De-Ti, He, Jian, Zhao, Wei-Cheng, Chen, Tuan-Tuan, Xie, Zong-Gui, Deng, Hai-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315107/
https://www.ncbi.nlm.nih.gov/pubmed/37405100
http://dx.doi.org/10.4240/wjgs.v15.i6.1232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315107/
https://www.ncbi.nlm.nih.gov/pubmed/37405100
http://dx.doi.org/10.4240/wjgs.v15.i6.1232

Ejemplares similares